retatrutide nash trial Results: 28.3% Weight Loss Data VisualAbstract: Retatrutide reduces body weight
Description
Available from: Blevins T, Pullman J, Malloy J, et al
[DOI] [PubMed] [Google Scholar] 216.Shintani T, Higashi S, Suzuki R, Takeuchi Y, Ikaga R, Yamazaki T, et al
Phase 2 trials investigated once-weekly subcutaneous doses ranging from 1 mg to 12 mg, administered via a gradual escalation schedule
The switch depends on your remaining beta cell function, current glucose control, overall health status, and treatment goals
Personalized medical advice is necessary to determine if one drug is a better fit than the other
